Home › Cases › Urosepsis — Obstructed Kidney
Urosepsis
Urosepsis — Obstructed Kidney
6 questions
Question 1 · Obstructed infected kidney
Correct answer: Obstructed infected kidney (pyonephrosis) — urological emergency. Sepsis from infected urine proximal to ureteric obstruction. Needs urgent decompression
Why
Obstructed infected kidney / pyonephrosis: stone obstruction → urinary stasis → infection cannot clear with antibiotics alone (obstruction is the cause). EMERGENCY: urgent decompression required regardless of antibiotic sensitivity. Decompression:
- ureteric stent (JJ stent) via cystoscopy OR
- percutaneous nephrostomy (PCN)
Without decompression: rapid deterioration → multi-organ failure → death.
Key point
Obstructed infected kidney: antibiotics alone insufficient — urgent decompression (JJ stent or nephrostomy). Obstruction prevents antibiotic efficacy.
Question 2 · Decompression options
Correct answer: JJ stent (retrograde, cystoscopy): preferred if patient stable, stone accessible, radiology not available urgently. PCN (nephrostomy): if retrograde fails, upper tract obstruction, patient too unstable for GA, anomalous anatomy
Why
Decompression choice: JJ stent: endoscopic (cystoscopy), retrograde → most commonly used, no external tube, often under LA/sedation. PCN (percutaneous nephrostomy): ultrasound-guided, external drainage tube, used if: retrograde fails, very ill patient, anomalous anatomy, difficult stone. Both effective at decompression — definitive stone treatment (ESWL, ureteroscopy) once sepsis resolved.
Key point
JJ stent (retrograde) vs PCN (nephrostomy): JJ stent first if accessible. PCN if retrograde fails, upper tract, or very unstable. Definitive stone Tx later.
Question 3 · Antibiotic escalation
Correct answer: Escalate to meropenem (carbapenem) based on sensitivities + clinical failure. Gram-negative sepsis from resistant organism — carbapenem required
Why
Urosepsis antibiotics: de-escalate when sensitivity permits; escalate when sensitivities show resistance. ESBL-producing E.coli: resistant to most penicillins/cephalosporins — carbapenem (meropenem/ertapenem) required. ESBL prevalence increasing. IDSA/BSAC guidelines: follow culture sensitivities. Carbapenem stewardship important — escalate appropriately but also de-escalate when possible.
Key point
ESBL E.coli in urosepsis: carbapenem required (meropenem). Escalate based on culture sensitivities. ESBL prevalence increasing.
Question 4 · Source control timing
Correct answer: Definitive treatment (ureteroscopy or ESWL) after full recovery from sepsis — typically 4-6 weeks. Remove temporary decompression (JJ stent or PCN) once stone cleared
Why
Staged approach to obstructed stone + sepsis:
- STAGE 1: emergency decompression (JJ stent or PCN) to control sepsis
- STAGE 2: elective definitive stone treatment (ureteroscopy, ESWL, PCNL) after full recovery (4-6 weeks)
Rationale: inflamed, oedematous ureter = higher perforation risk; unfit patient from sepsis = anaesthetic risk. Remove temporary drainage once stone cleared.
Key point
Obstructed stone + sepsis: staged approach. Decompression first (emergency), definitive stone treatment 4-6 weeks later when recovered.
Question 5 · Urosepsis organisms
Correct answer: E.coli (70-80%), Klebsiella, Proteus, Enterococcus. Empirical: IV co-amoxiclav or ceftriaxone or piperacillin-tazobactam based on local resistance patterns + patient risk factors
Why
Urosepsis organisms: E.coli most common (70-80%). Others: Klebsiella, Proteus, Enterococcus (resistant to many 1st line), Pseudomonas (hospital-acquired, catheter-related, structural abnormalities). Empirical: local antibiogram determines choice. Co-amoxiclav: adequate in community low-risk. Ceftriaxone/pip-tazo: if more severe/community ESBL risk. Meropenem: known ESBL/MDR risk or ICU.
Key point
Urosepsis: E.coli 70-80%. Empirical: co-amoxiclav or ceftriaxone (community). Pip-tazo or meropenem if ESBL risk, hospital-acquired.
Question 6 · Prevention of recurrence
Correct answer: High fluid intake (>2.5L/day). Normal/high dietary calcium (reduces gut oxalate absorption). Low oxalate diet (spinach, nuts, chocolate). Potassium citrate supplement (increases urine citrate — inhibits crystallisation)
Why
Calcium oxalate stone prevention:
- high fluid intake (most important — dilutes urine)
- Dietary calcium: INCREASE (paradox — dietary calcium binds intestinal oxalate → less absorbed → less urinary oxalate)
- Low oxalate foods
- Potassium citrate: citrate inhibits calcium crystal formation + raises urinary pH
- Thiazide diuretics: reduce urinary calcium
- Allopurinol: if hyperuricosuria
Key point
CaOx stones: high fluid (>2.5L), normal/high dietary calcium (reduces oxalate absorption), potassium citrate, low oxalate diet. NOT low calcium.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.